Track topics on Twitter Track topics that are important to you
101 rue de Tolbiac
PARIS CEDEX 13
Phone: 33 (0)1 44 23 60 00
Fax: 33 (0)1 45 85 68 56
On June 12, the term of the Chief Executive Officer (CEO) of the French National Institute of Health and Medical Research (INSERM) ends. The office of the current CEO, Yves Lévy, came under heavy cri...
(INSERM (Institut national de la santé et de la recherche médicale)) Thanks to a study conducted in pregnant women and their unborn children during the Zika epidemic in the French territories in the...
(INSERM (Institut national de la santé et de la recherche médicale)) With Immunoscore, a test devised by a team of researchers from Inserm and Université Paris Descartes and doctors from the Paris ...
(INSERM (Institut national de la santé et de la recherche médicale)) Dr Guillaume Canaud at the Necker-Enfants Malades Hospital AP-HP, the Paris Descartes University, Inserm and his team recently d...
(INSERM (Institut national de la santé et de la recherche médicale)) The National Institute for Biomedical Research (INRB) of Kinshasa and Inserm have characterized the nature of the Ebola virus res...
MELBOURNE, Australia and NANTES, France, April 16, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company fo...
To explore the feasibility of using several of Telix's clinical targeting agents with astatine
Dr. Jagadeesh Bayry from INSERM discusses his recent research in the field of immunology, and how T regulatory cells activate, rather than suppress, basophils.
The project is based on adult and paediatric cohorts among the largest ones in Paris and located at Saint Louis and Robert Debré hospitals. Experiments will be performed at INSERM Unit U8...
This study highlight genetics mutations with major effect in Crohn's Disease (CD) by WES in individuals affected and healthy individuals from EPIMAD Inserm InVS registry families.
The aim of this study is to validate in the context of liver transplantation, the interest of the cccDNA assay technique developed by the team of Professor Zoulim (INSERM U1052) on liver b...
The aim of the SURVIBIO study is to characterize acurate biomarkers for acute mesenteric ischemia, in particular at early stages. In the study, the development of biomarkers will be based...
Among Musculoskeletal disorders (MSD) the rupture of the Achilles tendon is the most common. Up today, the mechanical and elastic properties of the Achilles tendon are still unknown, and t...
Annapurna Therapeutics, headquartered in Paris, is a privately held company dedicated to advancing gene therapy for significant unmet medical needs. It is funded by Versant Ventur...
Founded in 2002 as a spin-off of INSERM U643/ITERT, one of the first research and transplantation centers in the world, and initially supported by the local incubator Atlanpole, TcLand is a biopharmac...
Spun off from Inserm (the French institute of health and medical research) in 2009, Sensorion is a biotech that specializes in the treatment of pathologies of the inner ear such a...
Laennec Tek is an independent CRO devoted to develop and implement innovative preclinical tests for drug discovery and safety pharmacology. The compagny was founded by Denis ESCANDE MD, PhD in februar...
We have published hundreds of Inserm news stories on BioPortfolio along with dozens of Inserm Clinical Trials and PubMed Articles about Inserm for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Inserm Companies in our database. You can also find out about relevant Inserm Drugs and Medications on this site too.